N° Verde Prenotazioni (rete fissa) 800.638638 | 02 99.95.99 (da cellulare)

Cardiac arrest and resuscitation Research Team (RESTART)

Tipologia: Cardiologia - Pneumologia

Principal Investigator: Dott. Savastano Simone

Cardiac arrest is the leading cause of death in the developed world, affecting 1 in 1,000 people every year. It is a major emergency with a low survival rate worldwide, very often less than 10%.  Knowledge of the epidemiology and causes of cardiac arrest, the prevention and prediction of events, and high-quality treatment, both pre-hospital and in-hospital, are essential to increase survival. Based on this, in 2015 we created an Out-of-Hospital Cardiac Arrest (OHCA) registry. At the beginning, it was focused on the province of Pavia (Italy) with 550,000 inhabitants, but in 2019 it was progressively implemented covering different provinces of the Lombardy region, thus reaching a total population of approximately 6.1 million inhabitants in 9 different provinces (Pavia, Bergamo, Brescia, Cremona, Lecco, Lodi, Mantova, Sondrio and Varese), and now it is called “Lombardia CARe” (ClinicalTrials.gov ID: NCT03197142). Our center,  Fondazione IRCCS Policlinico San Matteo of Pavia, is the Promoter Centre, and the main partner is AREU (Agenzia Regionale Emergenza Urgenza), the single Regional Agency where all electronic reports relating to each rescue mission are collected.

However, we believe that surviving cardiac arrest is not the end of the story but only the beginning of a specific treatment path. This is why the "REVIVE" project was subsequently born, as we argue that patients' evaluation and support are essential to improve the quality of life after cardiac arrest.

Due to the high mortality rate in the pre-hospital setting (~90-95%), the cause of cardiac arrest is often unknown and this could be an issue, mainly in young patients. To enhance the diagnostic possibility, we are coordinating a study that for the first time proposes collecting a blood sample in all the OHCA young victims (<=50 years old) of an entire region directly in the pre-hospital phase of the rescue for genetic analysis, with the final aim to disclose genetic variants to potentially explain the cause of the sudden cardiac arrest. This study, called “GenetiCA Study” (ClinicalTrials.gov ID: NCT06844851), will provide epidemiological data about the prevalence of genetic variants in the Lombardy region and, also, help family screening among the relatives of cardiac arrest victims.

Strictly linked to cardiac arrest, Ventricular Arrhythmias (VA) are also often a cause of death mainly when refractory to standard therapy and clustered into an electrical storm. Our research activity is also oriented to study a new strategy of defibrillation during cardiac arrest and to prevent it to become refractory. At this purpose, building on an international multicenter study that we coordinated (“STAR” study, ClinicalTrials.gov ID: NCT05720936), we are now leading an international consortium named “STAR” (Stellate Ganglion Block for Arrhythmic Storm) aimed at studying and implementing the stellate ganglion block (SGB) as an innovative and effective treatment for electrical storm (learn more about the STAR project). In parallel, we are conducting the “LIVE” study (ClinicalTrials.gov ID: NCT04168970), a translational project in the out-of-hospital setting that investigates stellate ganglion block as a feasible and effective adjunctive therapy for refractory ventricular arrhythmias during out-of-hospital cardiac arrest.

These are the main pillars on which our research is focused.
Much work has been done, but there are still many unsettled questions about cardiac arrest and ventricular arrhythmias.

Our Cardiac Arrest and Resuscitation Research Team (“RESTART”) has strong international collaborations and currently coordinates the COST Action “Precision Medicine for Cardiac Arrest (PREMEDICARE, CA24142)”, funded by the European Union.

  • Currao A et al. Impact of single vs. dual local anaesthetic regimen on the efficacy and safety of percutaneous stellate ganglion block for electrical storm: new insights from the STAR study. Eur Heart J Cardiovasc Pharmacother. 2026 May 19;12(3):198-208. 
     
  • Savastano S, et al. Electrical storm treatment by percutaneous stellate ganglion block: the STAR study. Eur Heart J. 2024 Mar 7;45(10):823-833. 
     
  • Baldi E et al. Association of Timing of Electrocardiogram Acquisition After Return of Spontaneous Circulation With Coronary Angiography Findings in Patients With Out-of-Hospital Cardiac Arrest. JAMA Netw Open. 2021 Jan 4;4(1):e2032875. 
     
  • Baldi E et al. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy. N Engl J Med. 2020 Jul 30;383(5):496-498. 
     
  • Baldi E et al. COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests. Eur Heart J. 2020 Jun 1;41(32):3045-3054.

  • Database management: REDCap
  • Statistical software: R, STATA, MedCalc
  • GIS software: QGIS
  • Other technology: 3D models (by 3D4MED) for stellate ganglion block training

  • Agenzia Regionale Emergenza Urgenza (AREU) - Lombardy (Italy)
  • Associazione Italiana di Aritmologia e Cardiostimolazione (AIAC)
  • Università degli Studi di Pavia (UNIPV)
  • Politecnico di Torino (PoliTo), Italy
  • Italian Resuscitation Council (IRC)
  • European Resuscitation Council (ERC)
  • Fondazione Ticino Cuore, Breganzona – Switzerland
  • EOC - Istituto Cardiocentro Ticino, Lugano – Switzerland
  • University of the Basque Countries - Spain
  • Hospital Clinic of Barcelona - Spain
  • University of Vienna - Austria
  • University of Calgary - Canada
  • Oslo University Hospital - Norway 
  • CHU Saint-Pierre, Bruxelles - Belgium
  • Essex Cardiothoracic Centre (CTC), Basildon University Hospital - United Kingdom (UK)
  • University of Cologne (Germany) 
  • Klinikum Fürth – Norimberga (Germany)
  • Amsterdam Resuscitation Studies (ARREST), Amsterdam UMC (Netherlands)
  • Sunnybrook Center for Prehospital Medicine - Toronto (Canada)
  • COST Action - European Cooperation in Science and Technology

Sara Bendotti, Carola Bonazzi, Laura Calabrese, Bianca Citterio, Alessia Currao, Simone Damiani, Elisa Gianino, Marco Mion, Arianna Morena, Margherita Paggi, Roberto Primi, Simona Procopio, Leila Ulmanova.

Dott. Savastano Simone

Dott. Baldi Enrico

Ultimo aggiornamento: 16/11/2026